Psoriasis study: D-2570 Tablet
Official title A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov ID: NCT07489885
What this study is testing
What is D-2570 Tablet?
An investigational oral tablet being studied as a potential treatment for moderate to severe plaque psoriasis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to determine how safe and effective D-2570 is for treating plaque psoriasis.
- Who it's for
- Adults who have moderate to severe plaque psoriasis.
- What's involved
- Participants will receive the drug D-2570 and be monitored for safety and effectiveness.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Participants with a diagnosis of plaque psoriasis with no significant flares of disease activity for at least 6 months before signing the informed...
- Participants have moderate to severe plaque psoriasis as defined by a total body surface area (BSA) ≥10%, a Psoriasis Area and Severity Index (PASI)...
- Within normal ranges of laboratory assessments
You likely can't join if
- Any comorbidities or past medical conditions as outlined in the protocol that would interfere with study assessments as deemed by the Investigator
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- Chula Vista, California, United States
- San Antonio, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; Chula Vista, California, United States; San Antonio, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.